Search

everythinglearnresearchcommunity

for

Search:↓

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Injecting alpha-melanocyte-stimulating hormone in mice improved skin healing and reduced scarring.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

Higher thyroid hormone levels may be linked to certain types of polycystic ovary syndrome.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Childhood growth hormone deficiency can be accurately diagnosed using gene expression data and random forest analysis.

PCOS involves hormonal and metabolic issues, increasing risks for diabetes and heart disease, and requires lifestyle changes and medication for management.

Provide individualized, supportive care for transgender and non-binary adolescents to improve their well-being.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

A boy with a new NR5A1 gene mutation has a sex development disorder without affecting his adrenal glands.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Western diet may cause male pattern baldness; low glycemic diet with magnesium could help.

Sex hormones likely don't affect atopic dermatitis in adolescents and adults.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Hair loss in men is common, treatable, but not curable.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

BLIMP1 is essential for skin maintenance but not for defining sebaceous gland progenitors.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Men with early-onset baldness have a higher chance of heart disease and clogged arteries.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.